Dan Leonard
Stock Analyst at RBC Capital
(4.59)
# 897
Out of 4,442 analysts
501
Total ratings
57.5%
Success rate
11.4%
Average return
Main Sectors:
Stocks Rated by Dan Leonard
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Initiated Coverage: Buy | $175 → $185 | $130.83 | +41.40% | 18 | Jun 12, 2026 | |
| NTRA Natera | Initiated Coverage: Buy | $290 → $275 | $234.76 | +17.14% | 18 | Jun 11, 2026 | |
| A Agilent Technologies | Maintained: Buy | $165 → $153 | $126.67 | +20.79% | 35 | May 26, 2026 | |
| BIO Bio-Rad Laboratories | Initiated Coverage: Buy | $335 → $320 | $270.32 | +18.38% | 29 | May 14, 2026 | |
| DHR Danaher | Initiated Coverage: Buy | $270 → $200 | $178.97 | +11.75% | 26 | May 14, 2026 | |
| ILMN Illumina | Initiated Coverage: Buy | $135 → $170 | $164.93 | +3.07% | 40 | May 14, 2026 | |
| RGEN Repligen | Initiated Coverage: Buy | $195 → $160 | $126.37 | +26.61% | 3 | May 14, 2026 | |
| TECH Bio-Techne | Initiated Coverage: Buy | $79 → $62 | $56.26 | +10.20% | 20 | May 14, 2026 | |
| TMO Thermo Fisher Scientific | Initiated Coverage: Hold | $615 → $490 | $469.35 | +4.40% | 27 | May 14, 2026 | |
| AVTR Avantor | Initiated Coverage: Hold | $11 → $9 | $9.43 | -4.56% | 12 | May 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $40 → $45 | $55.11 | -18.35% | 24 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $15 → $10 | $5.40 | +85.19% | 11 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $170 → $175 | $186.60 | -6.22% | 19 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $14 → $20 | $31.87 | -37.25% | 3 | Feb 19, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $355 → $340 | $336.39 | +1.07% | 6 | Feb 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $360 → $370 | $357.20 | +3.58% | 23 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $52 | $37.20 | +39.78% | 17 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $280 → $240 | $171.28 | +40.12% | 17 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $13 | $14.76 | -15.31% | 4 | Nov 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $260 → $220 | $142.67 | +54.20% | 7 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $24 → $28 | $16.87 | +65.98% | 3 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $300 → $305 | $473.48 | -35.58% | 4 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $1,530 → $1,350 | $1,156.64 | n/a | 14 | May 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $120 → $115 | $99.90 | n/a | 18 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $20 | $18.18 | n/a | 6 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 | $5.37 | n/a | 7 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | kr 960.00 | $844.20 | n/a | 1 | Apr 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $8 → $7 | $17.23 | n/a | 2 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 → $320 | $258.59 | n/a | 15 | Feb 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $160 → $145 | $197.18 | n/a | 15 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $86 → $95 | $124.23 | n/a | 7 | Oct 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $11 | $0.0001 | n/a | 1 | Jul 14, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $45 → $35 | $4.63 | n/a | 14 | Aug 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $280 | $143.92 | n/a | 1 | Dec 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $0.0004 | n/a | 5 | Jul 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $53.79 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.12 | n/a | 5 | Jun 20, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $90.53 | n/a | 1 | Jun 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.0001 | n/a | 4 | May 23, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $3.5 | $1.25 | n/a | 3 | May 11, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $15 | $0.7921 | n/a | 11 | Apr 12, 2016 |
Guardant Health
Jun 12, 2026
Initiated Coverage: Buy
Price Target: $175 → $185
Current: $130.83
Upside: +41.40%
Natera
Jun 11, 2026
Initiated Coverage: Buy
Price Target: $290 → $275
Current: $234.76
Upside: +17.14%
Agilent Technologies
May 26, 2026
Maintained: Buy
Price Target: $165 → $153
Current: $126.67
Upside: +20.79%
Bio-Rad Laboratories
May 14, 2026
Initiated Coverage: Buy
Price Target: $335 → $320
Current: $270.32
Upside: +18.38%
Danaher
May 14, 2026
Initiated Coverage: Buy
Price Target: $270 → $200
Current: $178.97
Upside: +11.75%
Illumina
May 14, 2026
Initiated Coverage: Buy
Price Target: $135 → $170
Current: $164.93
Upside: +3.07%
Repligen
May 14, 2026
Initiated Coverage: Buy
Price Target: $195 → $160
Current: $126.37
Upside: +26.61%
Bio-Techne
May 14, 2026
Initiated Coverage: Buy
Price Target: $79 → $62
Current: $56.26
Upside: +10.20%
Thermo Fisher Scientific
May 14, 2026
Initiated Coverage: Hold
Price Target: $615 → $490
Current: $469.35
Upside: +4.40%
Avantor
May 14, 2026
Initiated Coverage: Hold
Price Target: $11 → $9
Current: $9.43
Upside: -4.56%
May 7, 2026
Rated: Hold
Price Target: $40 → $45
Current: $55.11
Upside: -18.35%
Mar 9, 2026
Rated: Buy
Price Target: $15 → $10
Current: $5.40
Upside: +85.19%
Feb 25, 2026
Maintained: Hold
Price Target: $170 → $175
Current: $186.60
Upside: -6.22%
Feb 19, 2026
Maintained: Hold
Price Target: $14 → $20
Current: $31.87
Upside: -37.25%
Feb 13, 2026
Maintained: Buy
Price Target: $355 → $340
Current: $336.39
Upside: +1.07%
Feb 10, 2026
Maintained: Hold
Price Target: $360 → $370
Current: $357.20
Upside: +3.58%
Feb 9, 2026
Maintained: Hold
Price Target: $52
Current: $37.20
Upside: +39.78%
Feb 6, 2026
Maintained: Buy
Price Target: $280 → $240
Current: $171.28
Upside: +40.12%
Nov 5, 2025
Maintained: Buy
Price Target: $11 → $13
Current: $14.76
Upside: -15.31%
Oct 24, 2025
Maintained: Buy
Price Target: $260 → $220
Current: $142.67
Upside: +54.20%
Aug 6, 2025
Maintained: Hold
Price Target: $24 → $28
Current: $16.87
Upside: +65.98%
Jul 29, 2025
Downgraded: Sell
Price Target: $300 → $305
Current: $473.48
Upside: -35.58%
May 19, 2025
Upgraded: Buy
Price Target: $1,530 → $1,350
Current: $1,156.64
Upside: n/a
May 1, 2025
Upgraded: Buy
Price Target: $120 → $115
Current: $99.90
Upside: n/a
Mar 2, 2025
Maintained: Hold
Price Target: $25 → $20
Current: $18.18
Upside: n/a
Aug 8, 2024
Maintained: Hold
Price Target: $11
Current: $5.37
Upside: n/a
Apr 8, 2024
Maintained: Hold
Price Target: kr 960.00
Current: $844.20
Upside: n/a
Feb 14, 2023
Maintained: Sell
Price Target: $8 → $7
Current: $17.23
Upside: n/a
Feb 11, 2022
Maintained: Buy
Price Target: $340 → $320
Current: $258.59
Upside: n/a
Feb 4, 2022
Maintained: Hold
Price Target: $160 → $145
Current: $197.18
Upside: n/a
Oct 18, 2021
Maintained: Buy
Price Target: $86 → $95
Current: $124.23
Upside: n/a
Jul 14, 2020
Initiated Coverage: Buy
Price Target: $11
Current: $0.0001
Upside: n/a
Aug 14, 2019
Maintained: Hold
Price Target: $45 → $35
Current: $4.63
Upside: n/a
Dec 6, 2018
Initiated Coverage: Buy
Price Target: $280
Current: $143.92
Upside: n/a
Jul 8, 2016
Reiterated: Buy
Price Target: $7
Current: $0.0004
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $53.79
Upside: n/a
Jun 20, 2016
Reiterated: Buy
Price Target: n/a
Current: $25.12
Upside: n/a
Jun 16, 2016
Rated: Hold
Price Target: n/a
Current: $90.53
Upside: n/a
May 23, 2016
Reiterated: Buy
Price Target: $4
Current: $0.0001
Upside: n/a
May 11, 2016
Reiterated: Hold
Price Target: $4.5 → $3.5
Current: $1.25
Upside: n/a
Apr 12, 2016
Maintained: Buy
Price Target: $20 → $15
Current: $0.7921
Upside: n/a